T-72

T-72

Glomerulonephritis - II (T72-T95)

T. Hale Boggs (1914–72)

Isoform of Vascular Endothelial Cell Growth Inhibitor (VEGI72–251) Increases Interleukin-2 Production by Activation of T Lymphocytes

285. Ashbourne. M. 9 Nov. '72. Mrs. Thrale. T. E. Watson; collation by him 1920.—1788, No. 53.

Letter 72 She is suffering from late hours, in this point Sir T. Peyton submits to his wife, though he is often fault-finding

Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer

Accumulation of Vα7.2–Jα33 invariant T cells in human autoimmune inflammatory lesions in the nervous system

The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion.

B7–2 (CD86) is essential for the development of IL-4-producing T cells

B7.2-Ig fusion proteins enhance IL-4-dependent differentiation of tumor-sensitized CD8+ cytotoxic T lymphocyte precursors

Prosecutor v Bikindi (Simon), Judgment, Case no ICTR-01-72-T, ICL 709 (ICTR 2008), 2nd December 2008, Trial Chamber III (ICTR)

Oswald T. Avery 1877–1955, Colin MacLeod 1909–72, and Maclyn McCarty 1911–2005

T72. VERBAL MEMORY AND VOXEL BASED MORPHOMETRY IN FIRST EPISODE NON-AFFECTIVE PSYCHOSIS: A PROCESS ORIENTED APPROACH

Invariant Vα7.2-Jα33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells

CD154–CD40‐independent up‐regulation of B7‐2 on splenic antigen‐presenting cells and efficient T cell priming by staphylococcal enterotoxin A

A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis?

Protection against generalized autoimmunity of the nervous system (GANS), a novel animal model with combined features of EAE, EAN and EAU by a recombinant HIV-1 Tat37–72 peptide-based multiple T cell epitope vaccine

172G>T variant in the 5′ untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant